EPISODE · Dec 12, 2016 · 1 MIN
Dr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish)
from Oncology Information Group Podcast · host Dr. Denis Landaverde
Dr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish)
Embed this episode
Ready to play
Dr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish)
0:00
1:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Information Group Podcast?
This episode is 1 minute long.
When was this Oncology Information Group Podcast episode published?
This episode was published on December 12, 2016.
Can I download this Oncology Information Group Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!